Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant

Vaccine

Volumn 24, Issue 12, 2006, Pages 2213-2221

  Kende, Meir ^a   Giudice, Giuseppe Del ^b   Rivera, Noelia ^a   Hewetson, John ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b CHIRON VACCINES   (Italy)

Author keywords

Deglycosylated chain A ricin; Intranasal vaccination; Mucosal adjuvant

Indexed keywords

DEGLYCOSYLATED CHAIN RICIN A; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; RICIN A; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; DRUG SAFETY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; GLYCOSYLATION; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; RICIN; SAFETY; TOXOIDS; VACCINATION; VACCINES, SYNTHETIC;

EID: 32844463270     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.034     Document Type: Article

References (21)

1. B.D. Spengler The heat-labile enterotoxin of E. coli Microbiol Rev 56 1992 622 647
2. J.D. Clements, R.J. Yancy, and R.A. Finkelstein Properties of homogeneous heat-labile enterotoxin from E. coli Infect Immun 29 1980 91 97
3. R.J. Jackson, K. Fujihashi, J. Xu Amano, H. Kiyono, C.O. Elson, and J.R. McGhee Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant Infect Immun 61 1993 4272 4279
4. T.K. Sixma, S.E. Pronk, K.H. Kalk, E.S. Wartna, and B.E.M. van Zenten Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli Nature 351 1991 371 377
5. J. Holmgren Actions of cholera toxin and the prevention and treatment of cholera Nature 292 1981 413 417
6. 32P]ADP-ribosylation of proteins Methods Enzymol 195 1991 267 280
7. J. Moss, and M. Vaughan ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins Adv Enzymol Relat Areas Mol Biol 61 1988 303 379
8. S.T. Suguii Binding specificities of heat labile enterotoxins isolated from porcine nd human enterotoxigenic Escherichia coli for different gangliosides Can J Microbiol 35 1989 670 673
9. J. Holmgren, I. Lonroth, and L. Svennerholm Tissue receptor for cholera exotoxin postulated structure from studies with GM-1 gangliosyde and related glycolipids Infect Immun 8 1973 208 214
10. R. Rappuolli, and M. Pizza Structure and evolutionary aspects of ADP-ribosylating toxins J. Alouf J. Freer Sourcebook of bacterial protein toxins 1991 Academic Press 1 20
11. J. Moss, and M. Vaughan Toxin ADP-ribosyltransferases that act on adenylat-cyclase systems Methods Enzymol 106 1984 411 418
12. M. Field, M.C. Rao, and E.B. Chang Intestinal electrolyte transport and diarrheal disease N Engl J Med 321 1989 800 806
13. M.M. Giuliani, G. Del Giudice, V. Giannelli, G. Dougan, and G. Douce Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-rybosyltransferase activity J Exp Med 187 1998 1123 1132
14. R. Rappuoli, M. Pizza, G. Douce, and G. Dougan Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins Immunol Today 20 1999 493 500
15. J.D. Brackman, G. Ott, and D.T. O'Hagan Intranasal immunization in mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization Infect Immun 67 1999 4276 4279
16. D.T. O'Hagen, and R. Rappuoli Novel delivery systems for intranasal immunization with inactivated influenza vaccine Drug Deliv Syst Sci 1 2001 41 46
17. A.C. Guyton Measurement of respiratory volumes of laboratory animals Am J Phys 150 1947 70 77
18. J.F. Hewetson, P.V. Rivera, P.V. Lemley, M.L. Pitt, D.A. Cresia, and W.L. Thompson A formalinized toxoid for protection of mice from inhaled ricin Vaccine 4 1995 179 187
19. E.J. Ryan, E. McNeela, M. Pizza, R. Rappuoli, L. O'Neil, and K.H. Mills Modulation of innate and acquired immune response by Escherichia coli heat-labile toxin, distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity J Immunol 165 2000 5750 5759
20. E.J. Ryan, E. McNeela, G.A. Murphy, H. Stewart, D. O'Hagan, and M. Pizza Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvant for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on TH1 and Th2 cells Infect Immun 67 1999 6270 6280
21. B.C. Baudner, O. Balland, M.M. Giuliani, P. Von Hoegen, R. Rappuoli, and D. Betbeder Enhancement of protective efficacy following intranasal Immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles Infect Immun 70 2002 4785 4790